Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
European Heart Journal. Case Reports|February 12, 2025
Sinus arrest and syncope in a young patient with Epstein-Barr virus infection: a case reportGianmarco Sarto, Beatrice Simeone, Marco Bernardi, et al.Journal of Cardiovascular Pharmacology|July 7, 2026
Prophylactic ACE inhibition in anthracycline-induced cardiotoxicity: signal, context, and clinical uncertaintyBeatrice Simeone, Erica Rocco, Luigi Spadafora, et al.Expert Opinion on Pharmacotherapy|October 22, 2025
Optimizing selection of P2Y12 inhibiting therapy: clopidogrel, prasugrel or ticagrelorMattia Galli, Beatrice Simeone, Felice Gragnano, et al.Frontiers in Cardiovascular Medicine|August 22, 2024
Chronic Thromboembolic Pulmonary Hypertension: the therapeutic assessmentBeatrice Simeone, Enrico Maggio, Leonardo Schirone, et al.Frontiers in Cardiovascular Medicine|September 23, 2024
Chronic thromboembolic pulmonary hypertension: the diagnostic assessmentBeatrice Simeone, Enrico Maggio, Leonardo Schirone, et al.European Heart Journal. Acute Cardiovascular Care|March 12, 2026
Managing Bleeds on Anticoagulant therapy: A Practical Guide for CliniciansMattia Galli, Beatrice Simeone, Jurrien Ten Berg, et al.Antioxidants (Basel, Switzerland)|May 25, 2024
NOX2 as a Biomarker of Academic Performance: Evidence from University Students during ExaminationCristina Nocella, Alessandra D'Amico, Roberto Cangemi, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2024
Towards the Fifth Pillar for the Treatment of Heart Failure with Reduced Ejection Fraction: Vericiguat in Older and Complex PatientsLuigi Spadafora, Marco Bernardi, Gianmarco Sarto, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2025
Cardiovascular Safety of Bruton Tyrosine Kinase Inhibitors: From Ibrutinib to Next-Generation AgentsLuigi Spadafora, Federico Russo, Ewelina Bukowska-Olech, et al.Journal of the American College of Cardiology|September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.Pageof 3